Slamming the Courthouse Door: No Review of Alleged Statutory Violations in Task Order Procurements
Client Alert | less than 1 min read | 09.19.14
In SRA In'l v. U.S. (Sept. 15, 2014), the Federal Circuit held that the Court of Federal Claims lacked jurisdiction over a protest of an agency's OCI waiver made in the context of a task order procurement. The Federal Circuit found that the divestiture of jurisdiction over task order procurements in the Federal Acquisition Streamlining Act is complete and does not have an exception for alleged violations of statute or regulation.
Insights
Client Alert | 2 min read | 09.18.25
On September 9, 2025, the U.S. Department of Health and Human Services (HHS) and the Food and Drug Administration (HHS) issued a news release announcing an “aggressive[]” “crackdown” on direct-to-consumer pharmaceutical advertising. This release came on the heels of a Presidential Memorandum President Trump issued the same day directing HHS to “ensure transparency and accuracy in direct-to-consumer prescription drug advertisements,” and the FDA to “take action to enforce legal requirements that advertisements for prescription drugs be truthful and not misleading.”
Client Alert | 3 min read | 09.17.25
Client Alert | 4 min read | 09.17.25
Client Alert | 5 min read | 09.16.25
Bucking the Odds: Why Technology Companies Should Embrace Software Patents Today
